<H1>Chapter DOI: 10.1208/aapsj070241<br/>Cited-By Count: 13</H1><table border="1" width="30%"><tr><td>Total References</td><td>29</td></tr><tr><td>Springer references</td><td>14</td></tr><tr><td>Non Springer references</td><td>15</td></tr><tr><td>BibStructured Count</td><td width="10%">28</td></tr><tr><td>BibUnstructured Count</td><td width="10%">1</td></tr><tr><td>DOI already available in SpringerLink</td><td>20</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>1</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>1</td></tr><tr><td>DOI Obtained For Non Springer</td><td>0</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of population pharmacokinetic parameters from routine clinical data.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1977;5:445&#8211;479.</td><td><a href=http://dx.doi.org/10.1007/BF01061728>10.1007/BF01061728</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Beal SL, Sheiner LB. Estimating population pharmacokinetics.<Emphasis Type="Italic">Crit Rev Biomed Eng</Emphasis>. 1982;8:195&#8211;222.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibBook</td><td>United States Food and Drug Administration. Guidance for Industry: Population Pharmacokinetics. Washington, DC: United States Food and Drug Administration; 1999.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters III. Monoexponential model: Clinical pharmacokinetic data.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1983;11:303&#8211;319.</td><td><a href=http://dx.doi.org/10.1007/BF01061870>10.1007/BF01061870</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>al-Banna MK, Kelman AW, Whiting B. Experimental design and efficient parameter estimation in population pharmacokinetics.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1990;18:347&#8211;360.</td><td><a href=http://dx.doi.org/10.1007/BF01062273>10.1007/BF01062273</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Hashimoto Y, Sheiner LB. Designs for population pharmacodynamics: Value of pharmacokinetic data and population analysis.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1991;19:333&#8211;353.</td><td><a href=http://dx.doi.org/10.1007/BF03036255>10.1007/BF03036255</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibBook</td><td>Ette EI. Efficient parameter estimation in preclinical animal pharmacokinetics. PhD Thesis. University of Glasgow, Glasgow, Scotland, 1991.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Ette EI, Kelman AW, Howie CA, Whiting B. Efficient experimental design and estimation of population pharmacokinetic parameters in preclinical animal studies.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1995;12:729&#8211;737.</td><td><a href=http://dx.doi.org/10.1023/A:1016267811074>10.1023/A:1016267811074</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibChapter</td><td>Endrenyi L. Design of experiments for estimating enzyme and pharmacokinetic experiments. In: Endrenyi L, ed.<Emphasis Type="Italic">Kinetic Data Analysis of Enzyme and Pharmacokinetic Experiments</Emphasis>. New York: Plenum Press, 1981;137&#8211;167.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>D'Argenio DZ. Optimal sampling times for pharmacokinetic experiments.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1981;9:739&#8211;756.</td><td><a href=http://dx.doi.org/10.1007/BF01070904>10.1007/BF01070904</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Mori F, Di Stephano JJ III. Optimal nonuniform sampling interval and test-input design for identification of physiological systems from very limited data.<Emphasis Type="Italic">IEEE Trans auto Control</Emphasis>. 1979;AC-24:893&#8211;900.</td><td><a href=http://dx.doi.org/10.1109/TAC.1979.1102175>10.1109/TAC.1979.1102175</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibChapter</td><td>Landaw EM. Optimal design for individual parameter estimation in pharmacokinetics. In: Rowland M, Sheiner L, Steimer JL, eds.<Emphasis Type="Italic">Variability in Drug Therapy: Description, Estimation, and Control</Emphasis>. New York: Raven Press, 1985;187&#8211;200.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibBook</td><td>D'Argenio DZ, Shumitzky A. ADAPT II User's Guide:<Emphasis Type="Italic">Pharmacokinetic/Pharmacodynamic Systems Analysis Software</Emphasis>. Los Angeles, CA: Biomedical Simulations Resource; 1997.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR14</td><td>BibArticle</td><td>D'Argenio DZ. Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments.<Emphasis Type="Italic">Math Biosci</Emphasis>. 1990;99:105&#8211;118.</td><td><a href=http://dx.doi.org/10.1016/0025-5564(90)90141-K>10.1016/0025-5564(90)90141-K</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Tod M, Padoin C, Louchahi K, Moreau-Tod B, Petitjean O, Perret G. Implementation of OSPOP, an algorithm for the estimation of optimal sampling times by the ED, EID, and API criteria.<Emphasis Type="Italic">Comp Method Prog Biomed</Emphasis>. 1996;50:13&#8211;22.</td><td><a href=http://dx.doi.org/10.1016/0169-2607(96)01721-X>10.1016/0169-2607(96)01721-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Wang J, Endrenyi L. A computationally efficient approach for the design of population pharmacokinetic studies.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1992;20:279&#8211;294.</td><td><a href=http://dx.doi.org/10.1007/BF01062528>10.1007/BF01062528</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Ette</span> <span style='background:#DDDDDD'>EI</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Sun</span> <span style='background:#DDDDDD'>H</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Ludden</span> <span style='background:#DDDDDD'>TM</span></span></aug>. <span style='background:#FFD9B3'>Design of population pharmacokinetic studies</span>. <i>Proc Am Stat Assoc (Biopharmaceutics Section)</i>. <span style='background:#66FF66'>1994</span>;<span style='background:#D279FF'>487&#8211;492</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Fadiran EO, Jones CD, Ette EI. Designing population pharmacokinetic studies: Performance of mixed designs.<Emphasis Type="Italic">Eur J Drug Metab Pharmacokinet</Emphasis>. 2000;25:231&#8211;239.</td><td><a href=http://dx.doi.org/10.1007/BF03192320>10.1007/BF03192320</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, Author_FamilyName_2, FirstPage, Year, VolumeID, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Jonsson EN, Wade JR, Karlsson MO. Comparison of some practical sampling strategies for population pharmacokinetic studies.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1996;24:245&#8211;263.</td><td><a href=http://dx.doi.org/10.1007/BF02353491>10.1007/BF02353491</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Sun H, Ette EI, Ludden TM. On the recording of sample times and parameter estimation from repeated measures of pharmacokinetic data.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1996;24:637&#8211;650.</td><td><a href=http://dx.doi.org/10.1007/BF02353484>10.1007/BF02353484</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Mentre F, Mallet A, Baccar D. Optimal design in random-effects regression models.<Emphasis Type="Italic">Biometrika</Emphasis>. 1997;84:429&#8211;442.</td><td><a href=http://dx.doi.org/10.1093/biomet/84.2.429>10.1093/biomet/84.2.429</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Tod M, Mentre F, Merle Y, Mallet A. Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.<Emphasis Type="Italic">J Pharmacokinet Biopharm</Emphasis>. 1998;26:689&#8211;716.</td><td><a href=http://dx.doi.org/10.1023/A:1020703007613>10.1023/A:1020703007613</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Retout S, Mentre F. Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.<Emphasis Type="Italic">J Biopharm Stat</Emphasis>. 2003;13:209&#8211;227.</td><td><a href=http://dx.doi.org/10.1081/BIP-120019267>10.1081/BIP-120019267</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Duffull SB, Retout S, Mentre F. The use of simulated annealing for finding optimal population designs.<Emphasis Type="Italic">Comput Methods Programs Biomed</Emphasis>. 2001;69:25&#8211;35.</td><td><a href=http://dx.doi.org/10.1016/S0169-2607(01)00178-X>10.1016/S0169-2607(01)00178-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Hooker AC, Foracchia M, Dobbs MG, Vicini P. An evaluation of population D-optimal designs via pharmacokinetic simulations.<Emphasis Type="Italic">Ann Biomed Eng</Emphasis>. 2003;31:98&#8211;111.</td><td><a href=http://dx.doi.org/10.1114/1.1533074>10.1114/1.1533074</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Retout S, Mentre F, Bruno R. Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.<Emphasis Type="Italic">Stat Med</Emphasis>. 2002;21:2623&#8211;2639.</td><td><a href=http://dx.doi.org/10.1002/sim.1041>10.1002/sim.1041</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Retout S, Mentre F. Optimization of individual and population designs using Splus.<Emphasis Type="Italic">J Pharmacokinet Pharmacodyn</Emphasis>. 2003;30:417&#8211;443.</td><td><a href=http://dx.doi.org/10.1023/B:JOPA.0000013000.59346.9a>10.1023/B:JOPA.0000013000.59346.9a</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Ette EI, Sun H, Ludden TM. Balanced designs in longditudinal population pharmacokinetic studies.<Emphasis Type="Italic">J Clin Pharmacol</Emphasis>. 1998;38:417&#8211;423.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Aarons L, Balant LP, Mentre F, et al. Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies.<Emphasis Type="Italic">Eur J Clin Pharmacol</Emphasis>. 1996;49:251&#8211;254.</td><td><a href=http://dx.doi.org/10.1007/BF00226323>10.1007/BF00226323</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>